Counselors in Essex, NY Accepting Medicare
2 Counselors found. Showing 1 - 2
 Darla K Breckenridge, M.ED. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2261 Lake Shore Road, Essex, NY 12936 Phone: 518-963-7453 |
Mrs. Portia Xoliswa Allie-turco Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 16 Cross Rd, Essex, NY 12936 Phone: 518-963-7122 |
News Archive
Report highlights difficulties in uncovering Medicare fraud
Contractors paid tens of millions of taxpayer dollars to detect fraudulent Medicare claims are using inaccurate and inconsistent data that makes it extremely difficult to catch bogus bills submitted by crooks, according to an inspector general's report released Monday.
Pittcon conference registration opens for 2017
The Registration Committee today announced that conferee registration is now open for Pittcon 2017, the world's premier annual conference and exposition for laboratory science. The event will be held March 5-9, 2017, at the West Hall of McCormick Place, Chicago, IL.
U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis
The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves.
FDA clears ArthroCare's Spartan 6.5 Needled Anchor
ArthroCare® Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Spartan™ 6.5 Needled Anchor (Spartan). The Spartan device is a preloaded threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.
FDA grants Tarix's TXA127 Orphan Drug designation for stem cell engraftment and treatment of MDS
Tarix Pharmaceuticals today announced that it's drug, TXA127, has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) as a treatment to enhance engraftment in patients receiving a stem cell transplant. TXA127 has also received Orphan Drug designation for the treatment of Myelodysplastic Syndrome (MDS).
› Verified 7 days ago